The recent landmark success of gene-edited porcine kidney transplants into human recipients marks a turning point in the future of organ transplantation. With genetic engineering enabling immune-compatible organs, xenotransplantation is now a viable solution to address the critical organ shortage crisis. This panel will explore the scientific breakthroughs that made this possible, including CRISPR gene editing, immune system modulation, and advancements in bioengineering. Experts will discuss the clinical implications, regulatory considerations, and the path forward to making genetically engineered organs an option for patients in need. Join us for a deep dive into how this innovation is reshaping transplant medicine and what’s next for the field.